project . 2016 - 2019 . Closed

PRISM

Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916
Open Access mandate for Publications European Commission
  • Funder: European CommissionProject code: 115916 Call for proposal: H2020-JTI-IMI2-2015-03-two-stage
  • Funded under: H2020 | IMI2-RIA Overall Budget: 16,195,900 EURFunder Contribution: 8,080,000 EUR
  • Status: Closed
  • Start Date
    01 Apr 2016
    End Date
    30 Sep 2019
  • Detailed project information (CORDIS)
  • Open Access mandate
    Research Data: No
Description
The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. However, without a biological rationale for these disorders, drug development has dramatically stagnated in the past decades. In a coordinated effort encompassing academic experts, SMEs, patient and family organizations, regulators, ECNP and EFPIA partners, this project aims to develop a quantitative biological approach to the understanding and classification of neuropsychiatric diseases to accelerate the discovery and development of better treatments for patients. This project will concentrate on Schizophrenia (SZ), Alzheimer...
Description
The current nosology of neuropsychiatric disorders allows for a pragmatic approach to treatment choice, regulation and clinical research. However, without a biological rationale for these disorders, drug development has dramatically stagnated in the past decades. In a coordinated effort encompassing academic experts, SMEs, patient and family organizations, regulators, ECNP and EFPIA partners, this project aims to develop a quantitative biological approach to the understanding and classification of neuropsychiatric diseases to accelerate the discovery and development of better treatments for patients. This project will concentrate on Schizophrenia (SZ), Alzheimer...
Any information missing or wrong?Report an Issue